Role of Digitalis-Like Substance in the Hypertension of Streptozotocin-Induced Diabetes and Simulated Weightlessness in Rats

References

• Epstein E, Sowers J R. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403–418
   PubMed Web of Science ®Google Scholar
• Kloewski A S, Canessa M, Warren J H, Laffel L MP, Christleib A R, Knowler R C, Rand L T. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New Eng J Med 1988; 318: 140–145
   PubMed Web of Science ®Google Scholar
• Cabonell L F, Salom M G, Garcia-Estan J, Salazar F J, Ubeda M, Quesada T. Hemodynamic alteration in chronically conscious unrestrained diabetic rats. Am J Physiol 1987; 252: H900–905
   Google Scholar
• Jackson C V, Carrier G O. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovascular Pharmacology. 1983; 5: 260–265
   PubMed Web of Science ®Google Scholar
• Kohler L, Biollat N, Luthi P, Atkinson J, Peters-Haefeli L. Influence of streptozotocin-induced diabetes on blood pressure and on renin formation and release. Arch Pharmacol 1980; 313: 257–261
   Google Scholar
• Kusaka M, Kishi K, Sokabe H. Does so-called streptozotocin hypertension exist in rats. Hypertension 1987; 10: 517–521
   PubMed Web of Science ®Google Scholar
• O'Donnell M P, Kasiske B L, Keane W F. Glomerular hemodynamics and structural alterations in experimental diabetes mellitus. FASEB J 1988; 2: 2299–2347
   Google Scholar
• Chen S, Yuan C, Schooley J F, Haddy F J, Pamnani M B. A consistent model of insulin dependent diabetes mellitus hypertension. Am J Hypertension, (in press)
   Google Scholar
• Hostetter T H, Troy J L, Brenner B M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410–415
   PubMed Web of Science ®Google Scholar
• Anderson S, Brenner B M. Role of intraglomerular hypertension in the initiation and progression of renal disease. The kidney in hypertension, N B Kaplan, B M Brenner, J H Laragh. Raven Press, New York 1987; 67–75
   Google Scholar
• Kjeldsen K, Braendgard H, Sidenius P, Larsen J S, Norghard A AGE. Diabetes decreases Na K+pump concentration in skeletal muscles, heart ventricular muscle and peripheral nerves of rat. Diabetes 1987; 36: 842–846
   PubMed Web of Science ®Google Scholar
• Pierce G N, Dhalla N S. SaKrcolemmal Na+,K+ATPase activity in diabetic heart. Am J Physiol 1983; 245: C241–247
   Google Scholar
• Simmons D A, Kem E F, Winegrad A L, Martin D B. Basal phosphatidylinositide turnover controls aortic Na+,K+ATPase activity. J Clin Invest 1986; 77: 503–513
   PubMed Web of Science ®Google Scholar
• Greene D A, Lattimer S A, Sima A A. Sorbitol, phosphoinositides and sodium potassium ATPase in the pathogenesis of diabetic complications. New Eng J Med 1987; 316: 599–609
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Mathiesen E R, Deckert T, Giese J, Christensen N J, Bent-Hansen L, Nielson M D. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 610–617
   PubMed Web of Science ®Google Scholar
• Allen T J, Cooper M E, Obrien R C, Bach L A, Jackson B, Terums G. Glomerular filtration rate in streptozotocin-induced diabetic rats: Role of exchangeable sodium, vasoactive hormones and insulin therapy. Diabetes 1990; 39: 1182–1190
   PubMed Web of Science ®Google Scholar
• Haddy F J, Overbeck H W. The role of humoral agents in volume expanded hypertension. Life Science 1976; 19: 934–948
   Google Scholar
• Pamnani M S, Huot J S, Buggy L, Haddy F J. Demonstration of a humoral inhibitor of the Na+,K+pump in some models of experimental hypertension. Hypertension 1981; (Supple II) 3: II96–II101
   Google Scholar
• Huot S F, Pamnani M B, Clough D L, Haddy F J. The role of sodium intake, the Na+,K+pump and a ouabain-like humoral agent in the genesis of reduced renal mass hypertension. Am J Nephrol 1983; 3: 92–99
   PubMed Web of Science ®Google Scholar
• Pamnani M B, Burris J F, Jemionek J F, Huot S F, Price M, Fries E D, Haddy F J. Humoral Na+,K+pump activity in essential hypertension and in normotensive subjects after acute volume expansion. Am J Hypertension 1989; 2: 524–531
   PubMed Web of Science ®Google Scholar
• Hamlyn J M. Increased levels of a humoral digitalis-like factor in deoxycorticosterone acetate-induced hypertension in the pig. J Endocrin 1989; 122: 409–420
   PubMed Web of Science ®Google Scholar
• Blaustein M, Hamlyn J. Sodium transport inhibition, cell calcium, and hypertension: the natriuretic hormone/Na-Ca exchange/hypertension hypothesis. Am J Med 1984; 77(4A)45–49
   PubMed Web of Science ®Google Scholar
• Hamlyn J N, Ringel R, Schaefer J, Levinson P D, Hamilton B P, Kowarsaki A A, Blaustein M P. A circulating inhibitor of (Na+K+)-ATPase associated with essential hypertension. Nature 1982; 300: 1–3
   Web of Science ®Google Scholar
• Nakagawa H, Simanto K, Nakayowa M, Simura O. The role of endogenous digitalis-like factor in hypertensive mechanism in reduced renal mass hypertensive rats. Nippon Naibunpi Gakkai Zasshi 1993; 69: 462–574
   Google Scholar
• Leemen F J, Harmsen E, Yu H, Yuan B. Dietary sodium stimulates ouabain like activity in adrenalelctomized spontaneously hypertensive rats. Am J Physiol 1993; 265: H421–424
   Google Scholar
• Nakagawa H, Simanto K, Nakayowa M, Simura O. The role of endogenous digitalis-like factor in hypertensive mechanism in reduced renal mass hypertensive rats. Nippon Naibunpi Gakkai Zasshi 1993; 69: 462–574
   Google Scholar
• Hamlyn J M, Blaustein M P, Bova S, duCharme D W, Harris D W, Mandel F, Matthews W R, Ludens J H. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci Usa 1991; 88: 6259–6263
   PubMed Web of Science ®Google Scholar
• Pamnani M B, Whitehorn W, Clough D, Haddy F J. Effects of canrenone in rats with reduced renal mass saline hypertension. Am J Hypertension 1993; 3: 188–195
   Google Scholar
• Johnson P C. The erythropoietic effects of weightlessness. Chapter 12. Current concepts in Erythropoiesis, C DR Dunn, 1983
   Google Scholar
• Johnson P C, Driscoll T B, LeBlanc A D. Blood volume changes. Biomedical Results from Skylab, R S Johnston, L F Dietlein. NASA, Washington, DC 1977; 235–241, NASA SP-377 SPACE INTRODUCTION
   Google Scholar
• Leonard J I. Understanding metabolic alterations in space flight using quantitative models: Fluid and energy balance. Pergammon Press, Oxford 1985, Preprint IAF/IAA-85–325, 36th Congress. Int astro fed, Stockholm, 7–12 Oct
   Google Scholar
• Leach C S, Rambaut P C. Biochemical Responses of the Skylab Crewmen: An Overview. Biomedical Results from Skylab, R S Johnson, L F Deitlein. NASA, Washington, DC, 204–216, NASA SP-377
   Google Scholar
• Sangella G A, Shore A C, Markandu N D, MacGregor G A. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 1985; 2: 1208–1211
   PubMed Web of Science ®Google Scholar
• Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest 1985; 76: 1705–1709
   PubMed Web of Science ®Google Scholar
• Gonick H C, Kramer H J, Paul W, E L u. Circulating inhibitor of sodium-potassium activated adenosine triphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med 1977; 53: 329–334
   PubMedGoogle Scholar
• Gonick H C, Saldanha L F. A natriuretic principle derived from kidney tissue of volume-expanded rats. J Clin Invest 1975; 56: 247–255
   PubMed Web of Science ®Google Scholar
• Morey E R. Spaceflight and bone turnover: Correlation with a new rat model of weightlessness. BioScience 1979; 29: 168–172
   Web of Science ®Google Scholar
• Clough D L, Pamnani M B, Haddy F J. Decrease myocardial Na-K-ATPase activity in one-kidney, one-clip hypertensive rats. Am J Physiol 1983; 245: H244–251
   PubMed Web of Science ®Google Scholar
• Clough D L. Greater sensitivity to vanadate of rat renal relative to cardiac Na-K-ATPase. Life Sciences 1984; 35: 1937–1946
   PubMed Web of Science ®Google Scholar
• Chen S, Yuan C, Clough D, Schooley J, Haddy F J, Pamnani M B. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass. Hypertens 1993; 6: 397–406
   Web of Science ®Google Scholar
• Valdes R, Jr. Endogenous digoxin-immunoactive factor in human subjects. Fed Proc 1985; 44: 2800–2805, 1985
   PubMedGoogle Scholar
• Masugi F, Ogihara T, Hasegawa T, Kumahara Y. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension. Clin and Exper theory and practice; 1987; A9(7)1233–1242
   Google Scholar
• Sealey J E, Laragh J H. Radioimmunoassay of plasma renin activity. Semin Nucle Med 1975; 5: 189–202
   PubMedGoogle Scholar
• Feilding B A, Price D A, Houlton C A. Enzyme immunoassay for urinary albumin. Clin Chem 1983; 29: 355–357
   PubMed Web of Science ®Google Scholar
• Morey E R, Baylink D J. Inhibition on bone formation during spaceflight. Science 1978; 201: 1138–1141
   PubMed Web of Science ®Google Scholar
• Kimzye S L. Hematology and immunology studies. Biomedical Results from Skylab, R S Johnston, L F Deitlin. NASA, Washington, DC 1977; 249–282, NASA SP-377
   Google Scholar
• Loy A, Lurie K G, Ghosh A, Wilson J M, Macgregor L C, Matschinsky F M. Diabetes and myo-inositol paradox. Diabetes 1990; 39: 1305–1312
   PubMed Web of Science ®Google Scholar
• Pugliese G, Tilton R G, Speedy A, Santarell E, Eades D M, Province M A, Kilo C, Sherman W R, Williamson J R. Modulation of hemodynamic and vascular filtration changes in diabetic rats. Diabetes 1990; 39: 312–322
   PubMed Web of Science ®Google Scholar
• Gilmore J P, Zucker I LH. Contribution of vagal pathways to the renal response to head-out immersion in the non human primate. Cir Res 1978; 42: 263–487
   PubMed Web of Science ®Google Scholar